Full View

Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta‐analysis

M Komajda, M Boehm, JS Borer, I Ford… - European journal of …, 2018 - Wiley Online Library
Aims A network meta‐analysis (NMA) of all recommended drug groups for the treatment of
heart failure with reduced ejection fraction (HFrEF), including their combinations, was …
被引用次数：150 相关文章

Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis

M Komajda, M Böhm, JS Borer… - … journal of heart …, 2018 - pubmed.ncbi.nlm.nih.gov
Aims A network meta-analysis (NMA) of all recommended drug groups for the treatment of
heart failure with reduced ejection fraction (HFrEF), including their combinations, was …

Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis

M Komajda, M Böhm, JS Borer, I Ford… - European Journal of …, 2018 - eprints.gla.ac.uk
Aims: A network meta‐analysis (NMA) of all recommended drug groups for the treatment of
heart failure with reduced ejection fraction (HFrEF), including their combinations, was …

Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis.

M Komajda, M Böhm, JS Borer, I Ford… - European Journal of …, 2018 - europepmc.org
Aims A network meta-analysis (NMA) of all recommended drug groups for the treatment of
heart failure with reduced ejection fraction (HFrEF), including their combinations, was …

[引用][C] Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis

M Komajda, M Böhm, JS Borer, I Ford… - European Journal of …, 2018 - cir.nii.ac.jp
Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a
network meta-analysis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …